CAPN2 and pulmonary arterial hypertension: In Sugen/Hypoxia PAH rat model, inhibition of calpain-2 can prevent ERK1/2 activity, and reduces lactate-induced increases of PAH and pulmonary vascular remodeling (Kovacs et al., 2019).